All Stories

  1. Traditional Dietary Patterns and Risk of Mortality in a Longitudinal Cohort of the Salus in Apulia Study

    Article • Nutrients, April 2020, MDPI AG

    Francesco Panza, Dr Madia Lozupone

  2. The association of patient-reported symptoms and clinical and lung function parameters in patients with chronic obstructive pulmonary disease in stable phase

    Article • Expert Review of Respiratory Medicine, April 2020, Taylor & Francis

    Francesco Panza, Dr Madia Lozupone

  3. Development of disease-modifying drugs for frontotemporal dementia spectrum disorders

    Article • Nature Reviews Neurology, March 2020, Springer Science + Business Media

    Dr Bruno P Imbimbo, Francesco Panza, Dr Madia Lozupone

  4. Relationship between Inflammatory Food Consumption and Age-Related Hearing Loss in a Prospective Observational Cohort: Results from the Salus in Apulia Study

    Article • Nutrients, February 2020, MDPI AG

    MD Marco Castellana, Dr Madia Lozupone, Francesco Panza

  5. Time to test antibacterial therapy in Alzheimer’s disease

    Article • Brain, August 2019, Oxford University Press (OUP)

    Dr Madia Lozupone, Dr Bruno P Imbimbo, Francesco Panza

  6. Do BACE inhibitor failures in Alzheimer patients challenge the amyloid hypothesis of the disease?

    Article • Expert Review of Neurotherapeutics, May 2019, Taylor & Francis

    Dr Madia Lozupone, Dr Bruno P Imbimbo, Francesco Panza

  7. Power Doppler Ultrasound Findings before and after Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Pilot Study on Pain Reduction and Neovascularization Effect

    Article • Ultrasound in Medicine & Biology, May 2019, Elsevier

    Francesco Panza

  8. Disease-modifying therapies for tauopathies: agents in the pipeline

    Article • Expert Review of Neurotherapeutics, April 2019, Taylor & Francis

    Professor Francesco Panza, Dr Madia Lozupone, Professor GIANCARLO G LOGROSCINO, Dr Bruno P Imbimbo, Francesco Panza

  9. Hydroxytryptamine transporter gene-linked polymorphic region (5HTTLPR) is associated with delusions in Alzheimer’s disease

    Article • Translational Neurodegeneration, February 2019, Springer Science + Business Media

    Dr Madia Lozupone, Francesco Panza

  10. Amyloid-β immunotherapy for alzheimer disease: Is it now a long shot?

    Article • Annals of Neurology, January 2019, Wiley

    Dr Madia Lozupone, Dr Bruno P Imbimbo, Francesco Panza

  11. A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease

    Article • Nature Reviews Neurology, January 2019, Springer Science + Business Media

    Dr Madia Lozupone, Dr Bruno P Imbimbo, Francesco Panza

  12. Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life

    Article • Therapeutic Advances in Chronic Disease, November 2018, SAGE Publications

    Professor Francesco Panza, Dr Madia Lozupone, Francesco Panza, Dr Vittorio Dibello

  13. BACE inhibitors in clinical development for the treatment of Alzheimer’s disease

    Article • Expert Review of Neurotherapeutics, October 2018, Taylor & Francis

    Dr Madia Lozupone, Vittorio Dibello, Professor GIANCARLO G LOGROSCINO, Dr Vittorio Dibello, Dr Bruno P Imbimbo, Francesco Panza

  14. Social Dysfunction in Older Age and Relationships with Cognition, Depression, and Apathy: The GreatAGE Study

    Article • Journal of Alzheimer’s Disease, September 2018, IOS Press

    Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  15. Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review

    Article • Journal of Alzheimer’s Disease, June 2018, IOS Press

    Francesco Panza, Dr Madia Lozupone, Dr Vittorio Dibello

  16. Executive Dysfunction Detected with the Frontal Assessment Battery in Alzheimer’s Disease Versus Vascular Dementia

    Article • Journal of Alzheimer’s Disease, February 2018, IOS Press

    Francesco Panza, Dr Madia Lozupone

  17. Association of Antidementia Drugs and Mortality in Community-Dwelling Frail Older Patients With Dementia: The Role of Mortality Risk Assessment

    Article • Journal of the American Medical Directors Association, February 2018, Elsevier

    Francesco Panza

  18. Sensory Changes and the Hearing Loss–Cognition Link

    Article • JAMA Otolaryngology–Head & Neck Surgery, February 2018, American Medical Association (AMA)

    Francesco Panza

  19. Can a cognitive rehabilitation program in early stages of Parkinson's disease improve cognition, apathy and brain functional connectivity for up to 18 months?

    Article • European Journal of Neurology, December 2017, Wiley

    Professor Francesco Panza, Francesco Panza

  20. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults

    Article • The Lancet, December 2017, Elsevier

    Professor Erkin Mirrakhimov, Prof. Maciej Banach, Dr. Anwar Mahmoud Batieha, Dr. Stevo Popovic, Dr Andre Luiz Sena Guimaraes, Prof. Catherine Kyobutungi, Giovanni Veronesi, Francesco Panza, Professor Yousef Khader, Axel Carlsson, DR Bontha Veerraju Babu, Rajaa Al-Raddadi

  21. Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging

    Article • American Journal of Geriatric Psychiatry, November 2017, Elsevier

    Dr Madia Lozupone, Francesco Panza

  22. The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset

    Article • Expert Opinion on Biological Therapy, October 2017, Taylor & Francis

    Dr Madia Lozupone, Dr Bruno P Imbimbo, Francesco Panza, Dr Vittorio Dibello

  23. Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know?

    Article • Expert Opinion on Drug Safety, October 2017, Taylor & Francis

    Dr Madia Lozupone, Francesco Panza

  24. Phytochemicals in the Treatment of Alzheimer's Disease: A Systematic Review

    Article • Current Drug Targets, September 2017, Bentham Science Publishers

    Francesco Panza

  25. Cognitive frailty: a potential target for secondary prevention of dementia

    Article • Expert Opinion on Drug Metabolism & Toxicology, September 2017, Taylor & Francis

    Dr Madia Lozupone, Francesco Panza

  26. Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry

    Article • Expert Review of Proteomics, September 2017, Taylor & Francis

    Dr Madia Lozupone, Francesco Panza

  27. Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer’s Disease and Late-Life Cognitive Disorders: A Systematic Review

    Article • Journal of Alzheimer’s Disease, July 2017, IOS Press

    Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  28. Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity

    Article • Drugs, July 2017, Springer Science + Business Media

    Francesco Panza

  29. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Article • Nature Genetics, July 2017, Springer Science + Business Media

    Francesco Panza, Dr. Rita Guerreiro

  30. Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline

    Article • Journal of Alzheimer’s Disease, July 2017, IOS Press

    Professor GIANCARLO G LOGROSCINO, Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  31. Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke

    Article • Journal of the Neurological Sciences, July 2017, Elsevier

    Francesco Panza

  32. An Old Challenge with New Promises: A Systematic Review on Comprehensive Geriatric Assessment in Long-term Care Facilities

    Article • Rejuvenation Research, June 2017, Mary Ann Liebert Inc

    Francesco Panza, Dr Madia Lozupone, Dr Vittorio Dibello

  33. Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer’s Disease

    Article • Molecular Neurobiology, June 2017, Springer Science + Business Media

    Francesco Panza, Dr Madia Lozupone

  34. Change in Coefficient of Fatigability Following Rapid, Repetitive Movement Training in Post-Stroke Spastic Paresis: A Prospective Open-Label Observational Study

    Article • Journal of Stroke and Cerebrovascular Diseases, June 2017, Elsevier

    Francesco Panza

  35. Information and Communication Technologies for the Activities of Daily Living in Older Patients with Dementia: A Systematic Review

    Article • Journal of Alzheimer’s Disease, April 2017, IOS Press

    Francesco Panza

  36. Emerging biomarkers and screening for cognitive frailty

    Article • Aging Clinical and Experimental Research, March 2017, Springer Science + Business Media

    Francesco Panza, Dr Madia Lozupone

  37. Clinical and genetic analyses of familial and sporadic frontotemporal dementia patients in Southern Italy

    Article • Alzheimer s & Dementia, March 2017, Elsevier

    Francesco Panza

  38. Anti-tau vaccine in Alzheimer's disease: a tentative step

    Article • The Lancet Neurology, February 2017, Elsevier

    Francesco Panza

  39. Genetics of tailored medicine: Focus on CNS drugs

    Article • Microchemical Journal, February 2017, Elsevier

    Francesco Panza, Dr Madia Lozupone

  40. Three Decades of Comprehensive Geriatric Assessment: Evidence Coming From Different Healthcare Settings and Specific Clinical Conditions

    Article • Journal of the American Medical Directors Association, February 2017, Elsevier

    Francesco Panza

  41. Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging

    Article • Journal of the American Medical Directors Association, January 2017, Elsevier

    Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  42. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants

    Article • The Lancet, January 2017, Elsevier

    Dr. Anwar Mahmoud Batieha, Dr Andre Luiz Sena Guimaraes, Prof. Catherine Kyobutungi, Prof Suhad M Bahijri, Giovanni Veronesi, Francesco Panza, Professor Yousef Khader, Axel Carlsson, DR Bontha Veerraju Babu, Rajaa Al-Raddadi

  43. Bipolar Disorder and Frontotemporal Dementia: An Intriguing Association

    Article • Journal of Alzheimer’s Disease, December 2016, IOS Press

    Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  44. Relation of Statin Use and Mortality in Community-Dwelling Frail Older Patients With Coronary Artery Disease

    Article • The American Journal of Cardiology, December 2016, Elsevier

    Francesco Panza

  45. Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come?

    Article • Expert Opinion on Drug Metabolism & Toxicology, October 2016, Taylor & Francis

    Dr Madia Lozupone, Francesco Panza

  46. Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients

    Article • Expert Opinion on Emerging Drugs, October 2016, Taylor & Francis

    Dr Madia Lozupone, Dr Bruno P Imbimbo, Francesco Panza

  47. Non-Pharmacological Approaches in the Treatment of Dementia

    Article • September 2016, IntechOpen

    Francesco Panza

  48. Is Extracorporeal Shockwave Therapy Combined With Isokinetic Exercise More Effective Than Extracorporeal Shockwave Therapy Alone for Subacromial Impingement Syndrome? A Randomized Clinical Trial

    Article • Journal of Orthopaedic and Sports Physical Therapy, September 2016, Journal of Orthopaedic & Sports Physical Therapy (JOSPT)

    Professor Francesco Panza, Francesco Panza

  49. Tau-based therapeutics for Alzheimer’s disease: active and passive immunotherapy

    Article • Immunotherapy, September 2016, Future Medicine

    Professor Francesco Panza, Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  50. A Validation Study of Vascular Cognitive Impairment Genetics Meta-Analysis Findings in an Independent Collaborative Cohort

    Article • Journal of Alzheimer’s Disease, August 2016, IOS Press

    Professor Marcus R Munafo, Francesco Panza

  51. Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study

    Article • Journal of Alzheimer’s Disease, July 2016, IOS Press

    Francesco Panza

  52. Psychiatry meets pharmacogenetics for the treatment of revolving door patients with psychiatric disorders

    Article • Expert Review of Neurotherapeutics, July 2016, Taylor & Francis

    Francesco Panza, Dr Madia Lozupone

  53. High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective?

    Article • Expert Opinion on Drug Metabolism & Toxicology, June 2016, Taylor & Francis

    Francesco Panza, Dr Madia Lozupone

  54. Warfarin Treatment and All-Cause Mortality in Community-Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study

    Article • Journal of the American Geriatrics Society, June 2016, Wiley

    Francesco Panza

  55. The Role of Hearing Impairment in Cognitive Decline: Need for the Special Sense Assessment in Evaluating Cognition In Older Age

    Article • Neuroepidemiology, April 2016, Karger Publishers

    Francesco Panza

  56. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

    Article • The Lancet, April 2016, Elsevier

    Dr. Anwar Mahmoud Batieha, Dr Andre Luiz Sena Guimaraes, Francesco Panza, Professor Yousef Khader, DR Bontha Veerraju Babu

  57. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants

    Article • The Lancet, April 2016, Elsevier

    Dr. Anwar Mahmoud Batieha, Dr Andre Luiz Sena Guimaraes, Prof. Catherine Kyobutungi, Giovanni Veronesi, Francesco Panza, Professor Yousef Khader, Axel Carlsson

  58. Shared genetic contribution to ischemic stroke and Alzheimer's disease

    Article • Annals of Neurology, March 2016, Wiley

    Francesco Panza

  59. Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: a retrospective observational study

    Article • European Journal of Neurology, March 2016, Wiley

    Professor GIANCARLO G LOGROSCINO, Francesco Panza

  60. Delusions in Patients with Alzheimer’s Disease: A Multidimensional Approach

    Article • Journal of Alzheimer’s Disease, March 2016, IOS Press

    Professor Francesco Panza, Francesco Panza

  61. Tau-directed approaches for the treatment of Alzheimer’s disease: focus on leuco-methylthioninium

    Article • Expert Review of Neurotherapeutics, February 2016, Informa Healthcare

    Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  62. Tau aggregation inhibitors: the future of Alzheimer’s pharmacotherapy?

    Article • Expert Opinion on Pharmacotherapy, February 2016, Informa Healthcare

    Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  63. Klotho Gene and Selective Serotonin Reuptake Inhibitors: Response to Treatment in Late-Life Major Depressive Disorder

    Article • Molecular Neurobiology, February 2016, Springer Science + Business Media

    Dr Madia Lozupone, Francesco Panza

  64. Examination of level of knowledge in Italian general practitioners attending an education session on diagnosis and management of the early stage of Alzheimer's disease: pass or fail?

    Article • International Psychogeriatrics, January 2016, Cambridge University Press

    Dr Madia Lozupone, Dr Bruno P Imbimbo, Francesco Panza

  65. Development of an oncological-multidimensional prognostic index (Onco-MPI) for mortality prediction in older cancer patients

    Article • Journal of Cancer Research and Clinical Oncology, January 2016, Springer Science + Business Media

    Francesco Panza

  66. Pharmacogenetics in Neurodegenerative Diseases: Implications for Clinical Trials

    Article • January 2016, Karger Publishers

    Francesco Panza

  67. Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease

    Article • BioMed Research International, January 2016, Hindawi Publishing Corporation

    Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  68. Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson’s Disease? The Potential Role of Zolpidem in the Treatment of Parkinson’s Disease

    Article • Parkinson s Disease, January 2016, Hindawi Publishing Corporation

    Francesco Panza

  69. Alternative pharmacological treatment options for agitation in Alzheimer’s disease

    Article • Geriatric Care, November 2015, PAGEPress Publications

    Francesco Panza, Dr Madia Lozupone

  70. Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition

    Article • Rejuvenation Research, October 2015, Mary Ann Liebert Inc

    Francesco Panza

  71. Role of CYP2D6 Polymorphisms in the Outcome of Postoperative Pain Treatment

    Article • Pain Medicine, October 2015, Oxford University Press (OUP)

    Francesco Panza

  72. Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease

    Article • Expert Opinion on Pharmacotherapy, September 2015, Informa Healthcare

    Francesco Panza, Dr Madia Lozupone, Dr Bruno P Imbimbo

  73. Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study

    Article • BMJ Open, September 2015, BMJ

    Francesco Panza

  74. Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype

    Article • Journal of Alzheimer’s Disease, August 2015, IOS Press

    Francesco Panza

  75. Coffee Consumption Habits and the Risk of Mild Cognitive Impairment: The Italian Longitudinal Study on Aging

    Article • Journal of Alzheimer’s Disease, August 2015, IOS Press

    Dr Bruno P Imbimbo, Francesco Panza

  76. Ultrasound-Guided Injection of Botulinum Toxin Type A for Piriformis Muscle Syndrome: A Case Report and Review of the Literature

    Article • Toxins, August 2015, MDPI AG

    Francesco Panza

  77. Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331 288 participants

    Article • The Lancet Diabetes & Endocrinology, August 2015, Elsevier

    Dr. Anwar Mahmoud Batieha, Dr Andre Luiz Sena Guimaraes, Prof. Catherine Kyobutungi, Giovanni Veronesi, Francesco Panza, Professor Yousef Khader

  78. Statin Treatment and Mortality in Community-Dwelling Frail Older Patients with Diabetes Mellitus: A Retrospective Observational Study

    Article • PLoS ONE, June 2015, PLOS

    Francesco Panza

  79. Age-related hearing impairment and frailty in Alzheimer's disease: interconnected associations and mechanisms

    Article • Frontiers in Aging Neuroscience, June 2015, Frontiers

    Francesco Panza, Dr Bruno P Imbimbo

  80. Time to generalisation as a predictor of prognosis in amyotrophic lateral sclerosis: Table 1

    Article • Journal of Neurology Neurosurgery & Psychiatry, May 2015, BMJ

    Francesco Panza

  81. Measuring pharmacogenetics in special groups: geriatrics

    Article • Expert Opinion on Drug Metabolism & Toxicology, May 2015, Informa Healthcare

    Francesco Panza

  82. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life

    Article • Journal of Psychopharmacology, March 2015, SAGE Publications

    Francesco Panza

  83. A novel Alzheimer disease locus located near the gene encoding tau protein

    Article • Molecular Psychiatry, March 2015, Springer Science + Business Media

    Francesco Panza, Dr. Rita Guerreiro

  84. Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke

    Article • Journal of the Neurological Sciences, March 2015, Elsevier

    Francesco Panza

  85. Age-related hearing impairment—a risk factor and frailty marker for dementia and AD

    Article • Nature Reviews Neurology, February 2015, Nature

    Francesco Panza

  86. Epidemiology of age related hearing loss: A review

    Article • Hearing Balance and Communication, January 2015, Taylor & Francis

    Francesco Panza

  87. Perspective: The Challenge of Clinical Decision-Making for Drug Treatment in Older People. The Role of Multidimensional Assessment and Prognosis

    Article • Frontiers in Medicine, January 2015, Frontiers

    Francesco Panza

  88. Postural and Balance Disorders in Patients with Parkinson’s Disease: A Prospective Open-Label Feasibility Study with Two Months of Action Observation Treatment

    Article • Parkinson s Disease, January 2015, Hindawi Publishing Corporation

    Francesco Panza

  89. Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy

    Article • Neurological Sciences, December 2014, Springer Science + Business Media

    MD MARIA SOFIA COTELLI, Francesco Panza

  90. Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis

    Article • Deutsche Zeitschrift für Nervenheilkunde, December 2014, Springer Science + Business Media

    Francesco Panza

  91. Convergent genetic and expression data implicate immunity in Alzheimer's disease

    Article • Alzheimer s & Dementia, December 2014, Wiley

    Francesco Panza

  92. A pilot randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer's disease

    Article • International Journal of Geriatric Psychiatry, December 2014, Wiley

    Francesco Panza

  93. Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: A systematic review

    Article • The journal of nutrition health & aging, December 2014, Springer Science + Business Media

    Francesco Panza

  94. Caregiver burden characterization in patients with Alzheimer's disease or vascular dementia

    Article • International Journal of Geriatric Psychiatry, December 2014, Wiley

    Francesco Panza

  95. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques

    Article • Journal of the Neurological Sciences, December 2014, Elsevier

    Francesco Panza

  96. Plant-Based Nutraceutical Interventions against Cognitive Impairment and Dementia: Meta-Analytic Evidence of Efficacy of a Standardized Gingko biloba Extract

    Article • Journal of Alzheimer’s Disease, November 2014, IOS Press

    Francesco Panza

  97. Prevalence of diabetes and depressive symptomatology and their effect on mortality risk in elderly Italians: The Italian Longitudinal Study on Aging

    Article • Diabetes & Metabolism, November 2014, Elsevier

    Francesco Panza

  98. Possible role of alpha-lipoic acid in the treatment of peripheral nerve injuries

    Article • Journal of Brachial Plexus and Peripheral Nerve Injury, September 2014, Thieme Publishing Group

    Professor Marisa Megna, Francesco Panza

  99. Nutrition, frailty, and Alzheimer's disease

    Article • Frontiers in Aging Neuroscience, August 2014, Frontiers

    Francesco Panza

  100. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment

    Article • The Lancet Diabetes & Endocrinology, August 2014, Elsevier

    DR Bontha Veerraju Babu, Francesco Panza, Marit B Veierød

  101. Efficacy and safety studies of gantenerumab in patients with Alzheimer’s disease

    Article • Expert Review of Neurotherapeutics, August 2014, Informa Healthcare

    Francesco Panza, Dr Bruno P Imbimbo

  102. Amyloid-directed monoclonal antibodies for the treatment of Alzheimer’s disease: the point of no return?

    Article • Expert Opinion on Biological Therapy, June 2014, Informa Healthcare

    Francesco Panza, Dr Bruno P Imbimbo

  103. Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease

    Article • PLoS ONE, June 2014, PLOS

    Jordi Clarimon, Francesco Panza

  104. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial

    Article • Clinical Rehabilitation, June 2014, SAGE Publications

    Professor Francesco Panza, Francesco Panza

  105. Prevention of Late-life Cognitive Disorders: Diet-Related Factors, Dietary Patterns, and Frailty Models

    Article • Current Nutrition Reports, April 2014, Springer Science + Business Media

    Francesco Panza

  106. An intrinsically safe facility for forefront research and training on nuclear technologies — A zero-power experiment

    Article • The European Physical Journal Plus, April 2014, Springer Science + Business Media

    Francesco Panza

  107. Is there still any hope for amyloid-based immunotherapy for Alzheimerʼs disease?

    Article • Current Opinion in Psychiatry, March 2014, Wolters Kluwer Health

    Francesco Panza, Dr Bruno P Imbimbo

  108. Extracorporeal Shock Wave Therapy for the Treatment of Poststroke Plantar-Flexor Muscles Spasticity: A Prospective Open-Label Study

    Article • Topics in Stroke Rehabilitation, March 2014, Taylor & Francis

    Francesco Panza

  109. Hippocampal atrophy in people with memory deficits: results from the population-based IPREA study

    Article • International Psychogeriatrics, February 2014, Cambridge University Press

    Francesco Panza

  110. Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward

    Article • Expert Review of Clinical Immunology, February 2014, Informa Healthcare

    Francesco Panza, Dr Bruno P Imbimbo

  111. Mediterranean Diet and Cognitive Decline. A Lesson from the Whole-Diet Approach: What Challenges Lie Ahead?

    Article • Journal of Alzheimer’s Disease, January 2014, IOS Press

    Francesco Panza

  112. The Prevalence of Peripheral and Central Hearing Impairment and Its Relation to Cognition in Older Adults

    Article • Audiology and Neurotology, January 2014, Karger Publishers

    Francesco Panza

  113. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

    Article • Nature Genetics, October 2013, Springer Science + Business Media

    Francesco Panza

  114. Incidence of dementia: evidence for an effect modification by gender. The ILSA Study

    Article • International Psychogeriatrics, August 2013, Cambridge University Press

    Marianna Noale, Francesco Panza

  115. Neutron flux characterization of the SM1 sub-critical multiplying complex of the Pavia University

    Article • Progress in Nuclear Energy, August 2013, Elsevier

    Francesco Panza

  116. The Global Cardiovascular Risk Transition: Associations of Four Metabolic Risk Factors with National Income, Urbanization, and Western Diet in 1980 and 2008

    Article • Circulation, March 2013, Wolters Kluwer Health

    DR Bontha Veerraju Babu, Francesco Panza

  117. SBOTE Study: Extracorporeal Shock Wave Therapy Versus Electrical Stimulation After Botulinum Toxin Type A Injection for Post-Stroke Spasticity–A Prospective Randomized Trial

    Article • Ultrasound in Medicine & Biology, February 2013, Elsevier

    Francesco Panza

  118. The Serotonin Transporter Gene Locus in Late-Life Major Depressive Disorder

    Article • American Journal of Geriatric Psychiatry, January 2013, Elsevier

    Francesco Panza

  119. Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging

    Article • Alzheimer s & Dementia, December 2012, Wiley

    Dr Bruno P Imbimbo, Francesco Panza

  120. Forkhead-box-O1 locus y marcadores metabólicos en los ancianos: estudio de asociación

    Article • Revista Española de Geriatría y Gerontología, November 2012, Elsevier

    Francesco Panza

  121. Treatment of Late-Life Major Depressive Disorder With Selective Serotonin Reuptake Inhibitors Improves the Multidimensional Prognostic Index

    Article • Journal of Clinical Psychopharmacology, October 2012, Wolters Kluwer Health

    Francesco Panza

  122. Erratum: Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease

    Article • Molecular Psychiatry, September 2012, Springer Science + Business Media

    Francesco Panza

  123. TOMM40, APOE, and APOC1 in Primary Progressive Aphasia and Frontotemporal Dementia

    Article • Journal of Alzheimer’s Disease, September 2012, IOS Press

    Francesco Panza

  124. Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke

    Article • Acta Neurovegetativa, September 2012, Springer Science + Business Media

    Francesco Panza

  125. Vascular factors predict polyneuropathy in a non-diabetic elderly population

    Article • Neurological Sciences, August 2012, Springer Science + Business Media

    Francesco Panza

  126. Amyloid-related imaging abnormalities associated with immunotherapy in Alzheimer’s disease patients

    Article • Future Neurology, July 2012, Future Medicine

    Francesco Panza, Dr Bruno P Imbimbo

  127. Current Epidemiological Approaches to the Metabolic-Cognitive Syndrome

    Article • Journal of Alzheimer’s Disease, June 2012, IOS Press

    Francesco Panza

  128. Neuropsychiatric Symptoms and Functional Status in Alzheimer’s Disease and Vascular Dementia Patients

    Article • Current Alzheimer Research, June 2012, Bentham Science Publishers

    Francesco Panza

  129. Effectiveness of the Frequency Rhythmic Electrical Modulation System for the Treatment of Chronic and Painful Venous Leg Ulcers in Older Adults

    Article • Rejuvenation Research, June 2012, Mary Ann Liebert Inc

    Francesco Panza

  130. Changes in severity of depressive symptoms and mortality: the Italian Longitudinal Study on Aging

    Article • Psychological Medicine, April 2012, Cambridge University Press

    Francesco Panza

  131. A Multidimensional Prognostic Index in Common Conditions Leading to Death in Older Patients

    Article • Archives of Internal Medicine, April 2012, American Medical Association (AMA)

    Francesco Panza

  132. The metabolic syndrome, incidence of diabetes and mortality among the elderly: The Italian Longitudinal Study of Ageing

    Article • Diabetes & Metabolism, April 2012, Elsevier

    Francesco Panza

  133. Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease

    Article • Molecular Psychiatry, March 2012, Springer Science + Business Media

    Francesco Panza

  134. Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective?

    Article • International Journal of Geriatric Psychiatry, March 2012, Wiley

    Francesco Panza, Dr Bruno P Imbimbo

  135. Immunotherapy for Alzheimer’s disease: from anti-β-amyloid to tau-based immunization strategies

    Article • Immunotherapy, February 2012, Future Medicine

    Francesco Panza, Dr Bruno P Imbimbo

  136. Solanezumab for the treatment of mild-to-moderate Alzheimer’s disease

    Article • Expert Review of Clinical Immunology, February 2012, Informa Healthcare

    Francesco Panza, Dr Bruno P Imbimbo

  137. Addition of the Multidimensional Prognostic Index to the Estimated Glomerular Filtration Rate Improves Prediction of Long-Term All-Cause Mortality in Older Patients with Chronic Kidney Disease

    Article • Rejuvenation Research, February 2012, Mary Ann Liebert Inc

    Francesco Panza

  138. Comparing the Prognostic Accuracy for All-Cause Mortality of Frailty Instruments: A Multicentre 1-Year Follow-Up in Hospitalized Older Patients

    Article • PLoS ONE, January 2012, PLOS

    Francesco Panza

  139. The Serotonin Transporter Gene Locus in Late-Life Major Depressive Disorder

    Article • American Journal of Geriatric Psychiatry, January 2012, Elsevier

    Francesco Panza

  140. Usefulness of the multidimensional prognostic index (MPI) in the management of older patients with chronic kidney disease

    Article • Journal of Nephrology, January 2012, Wichtig

    Francesco Panza

  141. Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease

    Article • Ageing Research Reviews, January 2012, Elsevier

    Francesco Panza

  142. Effectiveness of Switching Therapy from Complexing Protein-containing Botulinum Toxin Type A to a Formulation with Low Immunogenicity in Spasticity after Stroke: A case report

    Article • Journal of Rehabilitation Medicine, January 2012, Acta Dermato-Venereologica

    Francesco Panza

  143. Treatment of Upper Limb Spasticity after Stroke: One-Year Safety and Efficacy of Botulinum Toxin Type A NT201

    Article • International Journal of Immunopathology and Pharmacology, January 2012, SAGE Publications

    Francesco Panza

  144. Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging

    Article • AGE, December 2011, Springer Science + Business Media

    Dr Bruno P Imbimbo, Francesco Panza

  145. Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease

    Article • Expert Opinion on Drug Discovery, December 2011, Informa Healthcare

    Francesco Panza, Dr Bruno P Imbimbo

  146. Interacting with γSecretase for Treating Alzheimer's Disease: From Inhibition to Modulation

    Article • Current Medicinal Chemistry, December 2011, Bentham Science Publishers

    Dr Bruno P Imbimbo, Francesco Panza

  147. Anti-β-Amyloid Immunotherapy for Alzheimers Disease: Focus on Bapineuzumab

    Article • Current Alzheimer Research, December 2011, Bentham Science Publishers

    Francesco Panza, Dr Bruno P Imbimbo

  148. Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging

    Article • Neurobiology of Aging, November 2011, Elsevier

    Francesco Panza

  149. Metabolic syndrome as a risk factor for neurological disorders

    Article • Cellular and Molecular Life Sciences, October 2011, Springer Science + Business Media

    Francesco Panza

  150. Effect of botulinum toxin type A and modified constraint-induced movement therapy on motor function of upper limb in children with obstetrical brachial plexus palsy

    Article • Child s Nervous System, October 2011, Springer Science + Business Media

    Francesco Panza

  151. The Genetics of the Human APOE Polymorphism

    Article • Rejuvenation Research, October 2011, Mary Ann Liebert Inc

    Francesco Panza

  152. Glycerophospholipids and glycerophospholipid-derived lipid mediators: A complex meshwork in Alzheimer’s disease pathology

    Article • Progress in Lipid Research, October 2011, Elsevier

    Francesco Panza

  153. Different models of frailty in predementia and dementia syndromes

    Article • The journal of nutrition health & aging, October 2011, Springer Science + Business Media

    Francesco Panza

  154. A Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short- and long-term all-cause mortality in older hospitalized patients with transient ischemic attack

    Article • Deutsche Zeitschrift für Nervenheilkunde, September 2011, Springer Science + Business Media

    Francesco Panza

  155. Pharmacogenetics in Geriatric Medicine: Challenges and Opportunities for Clinical Practice

    Article • Current Drug Metabolism, September 2011, Bentham Science Publishers

    Francesco Panza

  156. Metabolic Syndrome, Mild Cognitive Impairment and Dementia

    Article • Current Alzheimer Research, August 2011, Bentham Science Publishers

    Dr Bruno P Imbimbo, Francesco Panza

  157. Mediterranean Diet in Predementia and Dementia Syndromes

    Article • Current Alzheimer Research, August 2011, Bentham Science Publishers

    Dr Bruno P Imbimbo, Francesco Panza

  158. γ-secretase inhibitors for treating Alzheimer’s disease: rationale and clinical data

    Article • Clinical Investigation, August 2011, OMICS Publishing Group

    Francesco Panza

  159. Klotho locus, metabolic traits, and serum hemoglobin in hospitalized older patients: a genetic association analysis

    Article • AGE, June 2011, Springer Science + Business Media

    Francesco Panza

  160. Late-life depression and Alzheimer's disease: The glutamatergic system inside of this mirror relationship

    Article • Brain Research Reviews, June 2011, Elsevier

    Francesco Panza

  161. APOE and Alzheimer disease: a major gene with semi-dominant inheritance

    Article • Molecular Psychiatry, May 2011, Springer Science + Business Media

    Francesco Panza

  162. Monoclonal antibodies against β-amyloid (Aβ) for the treatment of Alzheimer's disease: the Aβ target at a crossroads

    Article • Expert Opinion on Biological Therapy, May 2011, Informa Healthcare

    Francesco Panza, Dr Bruno P Imbimbo

  163. The APOE Gene Locus in Frontotemporal Dementia and Primary Progressive Aphasia

    Article • Archives of Neurology, May 2011, American Medical Association (AMA)

    Francesco Panza

  164. Diet and Alzheimer’s disease risk factors or prevention: the current evidence

    Article • Expert Review of Neurotherapeutics, May 2011, Informa Healthcare

    Francesco Panza, Dr Bruno P Imbimbo

  165. Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging

    Article • AGE, April 2011, Springer Science + Business Media

    Francesco Panza

  166. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

    Article • Nature Genetics, April 2011, Springer Science + Business Media

    Francesco Panza, Dr. Rita Guerreiro

  167. Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations

    Article • Neurobiology of Aging, April 2011, Elsevier

    Francesco Panza

  168. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants

    Article • The Lancet, February 2011, Elsevier

    DR Bontha Veerraju Babu, Francesco Panza, Marit B Veierød

  169. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants

    Article • The Lancet, February 2011, Elsevier

    DR Bontha Veerraju Babu, Francesco Panza

  170. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants

    Article • The Lancet, February 2011, Elsevier

    Francesco Panza

  171. Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option?

    Article • Expert Opinion on Investigational Drugs, January 2011, Informa Healthcare

    Francesco Panza, Dr Bruno P Imbimbo

  172. Alcohol Consumption in Predementia and Dementia Syndromes

    Article • January 2011, Springer Science + Business Media

    Francesco Panza

  173. Dietary Fatty Acids, Cognitive Decline, and Dementia

    Article • January 2011, Springer Science + Business Media

    Francesco Panza

  174. Aluminium in the Diet, Cognitive Decline and Dementia

    Article • January 2011, Springer Science + Business Media

    Francesco Panza, Dr Bruno P Imbimbo

  175. Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene

    Article • International Journal of Alzheimer s Disease, January 2011, Hindawi Publishing Corporation

    Francesco Panza

  176. Polymorphisms in GlutathioneS-Transferase Omega-1 Gene and Increased Risk of Sporadic Alzheimer Disease

    Article • Rejuvenation Research, December 2010, Mary Ann Liebert Inc

    Francesco Panza, Dr Bruno P Imbimbo

  177. PLASMA LIPID DISTURBANCES AND COGNITIVE DECLINE

    Article • Journal of the American Geriatrics Society, December 2010, Wiley

    Francesco Panza

  178. Nutraceutical Properties of Mediterranean Diet and Cognitive Decline: Possible Underlying Mechanisms

    Article • Journal of Alzheimer’s Disease, November 2010, IOS Press

    Francesco Panza, Dr Bruno P Imbimbo

  179. Angiotensin-converting enzyme (ACE) genotypes and disability in hospitalized older patients

    Article • AGE, November 2010, Springer Science + Business Media

    Francesco Panza

  180. Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer’s disease

    Article • Immunotherapy, November 2010, Future Medicine

    Francesco Panza, Dr Bruno P Imbimbo

  181. PLASMA LEVELS OF N-3 POLYUNSATURATED FATTY ACIDS AND COGNITIVE DECLINE: POSSIBLE ROLE OF DEPRESSIVE SYMPTOMS AND APOLIPOPROTEIN E GENOTYPING

    Article • Journal of the American Geriatrics Society, November 2010, Wiley

    Francesco Panza

  182. Alcohol consumption and cardiovascular risk factors in older lifelong wine drinkers: The Italian Longitudinal Study on Aging

    Article • Nutrition Metabolism and Cardiovascular Diseases, November 2010, Elsevier

    Francesco Panza

  183. The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes

    Article • International Journal of Geriatric Psychiatry, October 2010, Wiley

    Francesco Panza

  184. Metabolic-cognitive syndrome: A cross-talk between metabolic syndrome and Alzheimer's disease

    Article • Ageing Research Reviews, October 2010, Elsevier

    Francesco Panza

  185. Pharmacogenetics of cytochrome P450 (CYP) in the elderly

    Article • Ageing Research Reviews, October 2010, Elsevier

    Francesco Panza

  186. Dietary Patterns and Protection Against Alzheimer Disease and Cognitive Decline

    Article • Archives of Neurology, October 2010, American Medical Association (AMA)

    Francesco Panza

  187. Prevalence of Aging-Associated Cognitive Decline in an Italian elderly population: results from cross-sectional phase of Italian PRoject on Epidemiology of Alzheimer’s disease (IPREA)

    Article • Aging Clinical and Experimental Research, October 2010, Springer Science + Business Media

    Francesco Panza

  188. The CALHM1 P86L Polymorphism is a Genetic Modifier of Age at Onset in Alzheimer's Disease: a Meta-Analysis Study

    Article • Journal of Alzheimer’s Disease, September 2010, IOS Press

    Francesco Panza

  189. Peripheral Antioxidant Markers in Mild Cognitive Impairment and its Progression to Dementia

    Article • Journal of Alzheimer’s Disease, September 2010, IOS Press

    Francesco Panza, Dr Bruno P Imbimbo

  190. Metabolic Syndrome and Cognitive Impairment: Current Epidemiology and Possible Underlying Mechanisms

    Article • Journal of Alzheimer’s Disease, September 2010, IOS Press

    Francesco Panza, Dr Bruno P Imbimbo

  191. Dietary Unsaturated Fatty Acids and Risk of Mild Cognitive Impairment

    Article • Journal of Alzheimer’s Disease, September 2010, IOS Press

    Dr Bruno P Imbimbo, Francesco Panza

  192. Effectiveness of botulinum toxin type A treatment of neck pain related to nocturnal bruxism: a case report

    Article • Journal of Chiropractic Medicine, September 2010, Elsevier

    Francesco Panza

  193. Is Insulin Resistant Brain State a Central Feature of the Metabolic-Cognitive Syndrome?

    Article • Journal of Alzheimer’s Disease, July 2010, IOS Press

    Francesco Panza, Dr Bruno P Imbimbo

  194. Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke

    Article • Brain Injury, June 2010, Taylor & Francis

    Professor Marisa Megna, Francesco Panza

  195. REVIEW: γ‐Secretase Inhibitors for the Treatment of Alzheimer's Disease: The Current State

    Article • CNS Neuroscience & Therapeutics, June 2010, Wiley

    Francesco Panza, Dr Bruno P Imbimbo

  196. Apolipoprotein E-related all-cause mortality in hospitalized elderly patients

    Article • AGE, April 2010, Springer Science + Business Media

    Francesco Panza

  197. Dietary fatty acids in dementia and predementia syndromes: Epidemiological evidence and possible underlying mechanisms

    Article • Ageing Research Reviews, April 2010, Elsevier

    Francesco Panza

  198. Aluminum in the Diet and Alzheimer's Disease: From Current Epidemiology to Possible Disease-Modifying Treatment

    Article • Journal of Alzheimer’s Disease, March 2010, IOS Press

    Francesco Panza, Dr Bruno P Imbimbo

  199. Interleukin 6–174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, February 2010, Elsevier

    Dr Bruno P Imbimbo, Francesco Panza

  200. Late-Life Depression, Mild Cognitive Impairment, and Dementia: Possible Continuum?

    Article • American Journal of Geriatric Psychiatry, February 2010, Elsevier

    Francesco Panza, Dr Bruno P Imbimbo

  201. Towards Disease-Modifying Treatment of Alzheimers Disease: Drugs Targeting β -Amyloid

    Article • Current Alzheimer Research, February 2010, Bentham Science Publishers

    Dr Bruno P Imbimbo, Francesco Panza

  202. EFFECT OF DONEPEZIL ON THE CONTINUUM OF DEPRESSIVE SYMPTOMS, MILD COGNITIVE IMPAIRMENT, AND PROGRESSION TO DEMENTIA

    Article • Journal of the American Geriatrics Society, January 2010, Wiley

    Francesco Panza

  203. Polymorphism C in the Serotonin Transporter Gene in Depression-Free Elderly Patients with Vascular Dementia

    Article • Dementia and Geriatric Cognitive Disorders, January 2010, Karger Publishers

    Francesco Panza

  204. Are NSAIDs useful to treat Alzheimer’s disease or mild cognitive impairment?

    Article • Frontiers in Aging Neuroscience, January 2010, Frontiers

    Dr Bruno P Imbimbo, Francesco Panza

  205. Effect of intrathecal baclofen, botulinum toxin type A and a rehabilitation programme on locomotor function after spinal cord injury: A case report

    Article • Journal of Rehabilitation Medicine, January 2010, Acta Dermato-Venereologica

    Francesco Panza

  206. Metabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Ageing

    Article • Journal of Neurology Neurosurgery & Psychiatry, December 2009, BMJ

    Francesco Panza

  207. All-Cause Mortality and Competing Risks of Fatal and Nonfatal Vascular Events in the Italian Longitudinal Study on Aging: Impact of Lipoprotein(a)

    Article • Rejuvenation Research, December 2009, Mary Ann Liebert Inc

    Francesco Panza

  208. Beyond the neurotransmitter-focused approach in treating Alzheimer’s Disease: drugs targeting β-amyloid and tau protein

    Article • Aging Clinical and Experimental Research, December 2009, Springer Science + Business Media

    Francesco Panza, Dr Bruno P Imbimbo

  209. Alcohol consumption and metabolic syndrome in the elderly: results from the Italian longitudinal study on aging

    Article • European Journal of Clinical Nutrition, November 2009, Springer Science + Business Media

    Francesco Panza

  210. Botulinum Toxin Type a in the Treatment of Painful Adductor Muscle Contracture After Total Hip Arthroplasty

    Article • Orthopedics, October 2009, SLACK, Inc.

    Francesco Panza

  211. Whole-Diet Approach: Working on a Criterion Validity for Age-Related Cognitive Decline and Mild Cognitive Impairment

    Article • Journal of the American Geriatrics Society, October 2009, Wiley

    Francesco Panza

  212. Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson’s disease

    Article • Deutsche Zeitschrift für Nervenheilkunde, September 2009, Springer Science + Business Media

    Francesco Panza

  213. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

    Article • Nature Genetics, September 2009, Springer Science + Business Media

    Francesco Panza

  214. Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease

    Article • Neurobiology of Aging, September 2009, Elsevier

    Francesco Panza

  215. The Multidimensional Prognostic Index (MPI), Based on a Comprehensive Geriatric Assessment Predicts Short- and Long-Term Mortality in Hospitalized Older Patients with Dementia

    Article • Journal of Alzheimer’s Disease, July 2009, IOS Press

    Francesco Panza

  216. Temporal Relationship between Depressive Symptoms and Cognitive Impairment: The Italian Longitudinal Study on Aging

    Article • Journal of Alzheimer’s Disease, July 2009, IOS Press

    Francesco Panza

  217. Disease-Modifying Approach to the Treatment of Alzheimerʼs Disease

    Article • Drugs & Aging, July 2009, Springer Science + Business Media

    Francesco Panza, Dr Bruno P Imbimbo

  218. Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease

    Article • Ageing Research Reviews, July 2009, Elsevier

    Francesco Panza

  219. Botulinum Toxin Type A in the Treatment of Focal Hand Dystonia After Surgical Treatment for Thumb Duplication

    Article • Orthopedics, July 2009, SLACK, Inc.

    Francesco Panza

  220. Mediterranean Dietary Pattern, Mild Cognitive Impairment, and Progression to Dementia

    Article • Archives of Neurology, July 2009, American Medical Association (AMA)

    Francesco Panza

  221. Short-term Effects of High-Intensity Laser Therapy Versus Ultrasound Therapy in the Treatment of People With Subacromial Impingement Syndrome: A Randomized Clinical Trial

    Article • Physical Therapy, May 2009, Oxford University Press (OUP)

    Professor Francesco Panza, Francesco Panza

  222. Alcohol Drinking, Cognitive Functions in Older Age, Predementia, and Dementia Syndromes

    Article • Journal of Alzheimer’s Disease, May 2009, IOS Press

    Francesco Panza

  223. POSSIBLE PREDICTORS OF VASCULAR COGNITIVE IMPAIRMENT–NO DEMENTIA

    Article • Journal of the American Geriatrics Society, April 2009, Wiley

    Francesco Panza

  224. APOLIPOPROTEIN E, DEMENTIA, AND HUMAN LONGEVITY

    Article • Journal of the American Geriatrics Society, April 2009, Wiley

    Francesco Panza

  225. Higher total cholesterol, cognitive decline, and dementia

    Article • Neurobiology of Aging, April 2009, Elsevier

    Francesco Panza

  226. Moderate Alcohol Consumption, Apolipoprotein E, and Neuroprotection

    Article • Archives of Neurology, April 2009, American Medical Association (AMA)

    Francesco Panza

  227. Possible Role of S-Adenosylmethionine, S-Adenosylhomocysteine, and Polyunsaturated Fatty Acids in Predementia Syndromes and Alzheimer's Disease

    Article • Journal of Alzheimer’s Disease, March 2009, IOS Press

    Francesco Panza

  228. Physical Disability and Depressive Symptomatology in an Elderly Population: A Complex Relationship. The Italian Longitudinal Study on Aging (ILSA)

    Article • American Journal of Geriatric Psychiatry, February 2009, Elsevier

    Francesco Panza

  229. Dietary Fatty Acids and Predementia Syndromes

    Article • The Scientific World JOURNAL, January 2009, Hindawi Publishing Corporation

    Francesco Panza

  230. N-3 polyunsaturated fatty acids and statins in heart failure

    Article • The Lancet, January 2009, Elsevier

    Francesco Panza

  231. Polyunsaturated Fatty Acid and S-Adenosylmethionine Supplementation in Predementia Syndromes and Alzheimer's Disease: A Review

    Article • The Scientific World JOURNAL, January 2009, Hindawi Publishing Corporation

    Francesco Panza, Dr Bruno P Imbimbo

  232. Role of Biphosphonates and Lymphatic Drainage Type Leduc in the Complex Regional Pain Syndrome (Shoulder–Hand Syndrome)

    Article • Pain Medicine, January 2009, Oxford University Press (OUP)

    Professor Marisa Megna, Francesco Panza

  233. RESPONSE LETTER TO DR. MELO ET AL.

    Article • Journal of the American Geriatrics Society, January 2009, Wiley

    Francesco Panza

  234. Acoustic analysis of swallowing sounds: A new technique for assessing dysphagia

    Article • Journal of Rehabilitation Medicine, January 2009, Acta Dermato-Venereologica

    Francesco Panza

  235. Cognitive behavioural group therapy in mild cognitive impairment: Intervention with a cognitive or behavioural/psychological focus?

    Article • Journal of Rehabilitation Medicine, January 2009, Acta Dermato-Venereologica

    Francesco Panza

  236. Diabetes as a Risk Factor for Cognitive Decline in Older Patients

    Article • Dementia and Geriatric Cognitive Disorders, December 2008, Karger Publishers

    Francesco Panza

  237. Predementia and Dementia Syndromes: Possible Role of Lipoprotein Metabolism

    Article • Vascular Disease Prevention, December 2008, Bentham Science Publishers

    Francesco Panza

  238. Hypertension and Mild Cognitive Impairment Subtypes

    Article • Archives of Neurology, July 2008, American Medical Association (AMA)

    Francesco Panza

  239. BEYOND CORONARY ARTERY DISEASE: ROSUVASTATIN IN OLDER PATIENTS WITH ISCHEMIC SYSTOLIC HEART FAILURE

    Article • Journal of the American Geriatrics Society, July 2008, Wiley

    Francesco Panza

  240. MILD COGNITIVE IMPAIRMENT: DEMENTIA RISK FACTOR OR HIGH-RISK STATE FOR PROGRESSION TO DEMENTIA?

    Article • Journal of the American Geriatrics Society, July 2008, Wiley

    Francesco Panza

  241. Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment. The Italian Longitudinal Study on Aging

    Article • International Journal of Geriatric Psychiatry, July 2008, Wiley

    Francesco Panza

  242. Dietary fatty acids, age-related cognitive decline, and mild cognitive impairment

    Article • The journal of nutrition health & aging, July 2008, Springer Science + Business Media

    Francesco Panza

  243. Vascular risk factors, alcohol intake, and cognitive decline

    Article • The journal of nutrition health & aging, July 2008, Springer Science + Business Media

    Francesco Panza

  244. Alcohol Use, Thiamine Deficiency, and Cognitive Impairment

    Article • JAMA, June 2008, American Medical Association (AMA)

    Francesco Panza

  245. The RELN Locus in Alzheimer's Disease

    Article • Journal of Alzheimer’s Disease, June 2008, IOS Press

    Francesco Panza

  246. Polymorphism C in the serotonin transporter gene (SLC6A4) in questionable dementia and Alzheimer's disease

    Article • Neuroscience Letters, June 2008, Elsevier

    Francesco Panza

  247. BOTULINUM TOXIN TYPE A IN THE TREATMENT OF SIALORRHEA IN PARKINSON'S DISEASE

    Article • Journal of the American Geriatrics Society, April 2008, Wiley

    Professor Marisa Megna, Francesco Panza

  248. S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in predementia syndromes and Alzheimer's disease

    Article • Neurobiology of Aging, March 2008, Elsevier

    Francesco Panza

  249. Association Analysis of GRIN2B, Encoding N-Methyl-D-Aspartate Receptor 2B Subunit, and Alzheimer’s Disease

    Article • Dementia and Geriatric Cognitive Disorders, February 2008, Karger Publishers

    Francesco Panza

  250. Short arm of chromosome 11 and sporadic Alzheimer's disease: Catalase and cathepsin D gene polymorphisms

    Article • Neuroscience Letters, February 2008, Elsevier

    Francesco Panza

  251. Calcium metabolism and vitamin D in the extreme longevity

    Article • Experimental Gerontology, February 2008, Elsevier

    Francesco Panza

  252. Depressive Symptoms, Vascular Risk Factors and Mild Cognitive Impairment

    Article • Dementia and Geriatric Cognitive Disorders, January 2008, Karger Publishers

    Francesco Panza

  253. Lifestyle-related factors in predementia and dementia syndromes

    Article • Expert Review of Neurotherapeutics, January 2008, Informa Healthcare

    Francesco Panza

  254. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: A case for switching therapy?

    Article • Journal of Rehabilitation Medicine, January 2008, Acta Dermato-Venereologica

    Francesco Panza

  255. CIND AND MCI IN THE ITALIAN ELDERLY: FREQUENCY, VASCULAR RISK FACTORS, PROGRESSION TO DEMENTIA

    Article • Neurology, December 2007, Wolters Kluwer Health

    Francesco Panza

  256. Lipoproteins, Vascular-Related Genetic Factors, and Human Longevity

    Article • Rejuvenation Research, December 2007, Mary Ann Liebert Inc

    Francesco Panza

  257. Interleukin 6 Variable Number of Tandem Repeats (VNTR) Gene Polymorphism in Centenarians

    Article • Annals of Human Genetics, November 2007, Wiley

    Francesco Panza

  258. LIFESTYLE-RELATED FACTORS, ALCOHOL CONSUMPTION, AND MILD COGNITIVE IMPAIRMENT

    Article • Journal of the American Geriatrics Society, October 2007, Wiley

    Francesco Panza

  259. Heterogeneity of mild cognitive impairment and other predementia syndromes in progression to dementia

    Article • Neurobiology of Aging, October 2007, Elsevier

    Francesco Panza

  260. CHANGE OF DIAGNOSES IN PROBABLE AND POSSIBLE MILD COGNITIVE IMPAIRMENT: THE ITALIAN LONGITUDINAL STUDY ON AGING

    Article • Journal of the American Geriatrics Society, September 2007, Wiley

    Francesco Panza

  261. Progression to Dementia in Probable and Possible Mild Cognitive Impairment

    Article • Archives of Neurology, August 2007, American Medical Association (AMA)

    Francesco Panza

  262. Differences in allele frequencies of ACE I/D polymorphism between Northern and Southern Europe at different ages

    Article • Atherosclerosis, August 2007, Elsevier

    Francesco Panza

  263. Incident Occurrence of Depressive Symptoms among Patients with Mild Cognitive Impairment – The Italian Longitudinal Study on Aging

    Article • Dementia and Geriatric Cognitive Disorders, June 2007, Karger Publishers

    Francesco Panza

  264. Alcohol consumption, mild cognitive impairment, and progression to dementia

    Article • Neurology, May 2007, Wolters Kluwer Health

    Francesco Panza

  265. EFFECT OF A CLINICAL STROKE ON THE RISK OF DEMENTIA IN A PROSPECTIVE COHORT

    Article • Neurology, May 2007, Wolters Kluwer Health

    Francesco Panza

  266. Ten-year risk of dementia in subjects with mild cognitive impairment

    Article • Neurology, April 2007, Wolters Kluwer Health

    Francesco Panza

  267. Whole-Diet Approach, Mediterranean Diet, and Alzheimer Disease

    Article • Archives of Neurology, April 2007, American Medical Association (AMA)

    Francesco Panza

  268. Apolipoprotein E Genotypes in Hospitalized Elderly Patients with Vascular Dementia

    Article • Dementia and Geriatric Cognitive Disorders, March 2007, Karger Publishers

    Francesco Panza

  269. Mild cognitive impairment: Risk of Alzheimer disease and rate of cognitive decline

    Article • Neurology, March 2007, Wolters Kluwer Health

    Francesco Panza

  270. DIETARY POLYUNSATURATED FATTY ACID SUPPLEMENTATION, PREDEMENTIA SYNDROMES, AND ALZHEIMER'S DISEASE

    Article • Journal of the American Geriatrics Society, March 2007, Wiley

    Francesco Panza

  271. Possible Role of Unsaturated Fatty Acids in a 14-Day Healthy Longevity Lifestyle Program

    Article • American Journal of Geriatric Psychiatry, March 2007, Elsevier

    Francesco Panza

  272. The Missing ApoE Allele

    Article • Annals of Human Genetics, January 2007, Wiley

    Francesco Panza

  273. TOTAL CHOLESTEROL LEVELS AND THE RISK OF MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE

    Article • Journal of the American Geriatrics Society, January 2007, Wiley

    Francesco Panza

  274. Mediterranean diet, mild cognitive impairment, and Alzheimer’s disease

    Article • Experimental Gerontology, January 2007, Elsevier

    Francesco Panza

  275. APOLIPOPROTEIN E GENOTYPES IN MILD COGNITIVE IMPAIRMENT SUBTYPES

    Article • Journal of the American Geriatrics Society, December 2006, Wiley

    Francesco Panza

  276. DIET, CHOLESTEROL METABOLISM, AND ALZHEIMER'S DISEASE: APOLIPOPROTEIN E AS A POSSIBLE LINK?

    Article • Journal of the American Geriatrics Society, December 2006, Wiley

    Francesco Panza

  277. Macronutrients, aluminium from drinking water and foods, and other metals in cognitive decline and dementia

    Article • Journal of Alzheimer’s Disease, November 2006, IOS Press

    Francesco Panza

  278. Adherence to a Mediterranean dietary pattern and risk of Alzheimer's disease

    Article • Annals of Neurology, November 2006, Wiley

    Francesco Panza

  279. Dietary intake of unsaturated fatty acids and age-related cognitive decline: A 8.5-year follow-up of the Italian Longitudinal Study on Aging

    Article • Neurobiology of Aging, November 2006, Elsevier

    Francesco Panza

  280. Current knowledge of chromosome 12 susceptibility genes for late-onset Alzheimer's disease

    Article • Neurobiology of Aging, November 2006, Elsevier

    Francesco Panza

  281. WHOLE-DIET APPROACH AND RISK OF CHRONIC DISEASE: LIMITS AND ADVANTAGES

    Article • Journal of the American Geriatrics Society, November 2006, Wiley

    Francesco Panza

  282. Low incidence for predementia and dementia syndromes in a brain imaging study

    Article • Annals of Neurology, November 2006, Wiley

    Francesco Panza

  283. Cardiovascular Factors and Cognitive Impairment: A Role for Unsaturated Fatty Acids and Mediterranean Diet?

    Article • The American Journal of Cardiology, October 2006, Elsevier

    Francesco Panza

  284. Efficacy and tolerability of combined treatment with l-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus

    Article • Atherosclerosis, October 2006, Elsevier

    Francesco Panza

  285. Stroke and Memory Decline: A Question of Degenerative or Vascular Origin

    Article • Archives of Neurology, September 2006, American Medical Association (AMA)

    Francesco Panza

  286. Serum total cholesterol as a biomarker for Alzheimer’s disease: Mid-life or late-life determinations?

    Article • Experimental Gerontology, September 2006, Elsevier

    Francesco Panza

  287. PREVALENCE RATES OF MILD COGNITIVE IMPAIRMENT SUBTYPES AND PROGRESSION TO DEMENTIA

    Article • Journal of the American Geriatrics Society, September 2006, Wiley

    Francesco Panza

  288. Sex Differences in the Association of Apolipoprotein E and Angiotensin-Converting Enzyme Gene Polymorphisms With Healthy Aging and Longevity: A Population-Based Study From Southern Italy

    Article • The Journals of Gerontology Series A, September 2006, Oxford University Press (OUP)

    Francesco Panza

  289. Lipid metabolism in cognitive decline and dementia

    Article • Brain Research Reviews, August 2006, Elsevier

    Francesco Panza

  290. Predementia and Dementia Syndromes: Possible Role of Lipoprotein Metabolism

    Article • Vascular Disease Prevention, August 2006, Bentham Science Publishers

    Francesco Panza

  291. Cognitive frailty: Predementia syndrome and vascular risk factors

    Article • Neurobiology of Aging, July 2006, Elsevier

    Francesco Panza

  292. Dietary fatty acids intakes and rate of mild cognitive impairment. The Italian Longitudinal Study on Aging

    Article • Experimental Gerontology, June 2006, Elsevier

    Francesco Panza

  293. Cerebrovascular disease in the elderly: lipoprotein metabolism and cognitive decline

    Article • Aging Clinical and Experimental Research, April 2006, Springer Science + Business Media

    Francesco Panza

  294. Nutritional factors, cognitive decline, and dementia

    Article • Brain Research Bulletin, March 2006, Elsevier

    Francesco Panza

  295. Circulating biomarkers of cognitive decline and dementia

    Article • Clinica Chimica Acta, February 2006, Elsevier

    Francesco Panza

  296. Candidate genes for late-onset Alzheimer's disease: Focus on chromosome 12

    Article • Mechanisms of Ageing and Development, January 2006, Elsevier

    Francesco Panza

  297. Current Epidemiology of Mild Cognitive Impairment and Other Predementia Syndromes

    Article • American Journal of Geriatric Psychiatry, August 2005, Elsevier

    Francesco Panza

  298. The Cathepsin D Gene Exon 2 (C224T) Polymorphism and Sporadic Alzheimer's Disease in European Populations

    Article • The Journals of Gerontology Series A, August 2005, Oxford University Press (OUP)

    Francesco Panza

  299. Dietary fatty acids intake: possible role in cognitive decline and dementia

    Article • Experimental Gerontology, April 2005, Elsevier

    Francesco Panza

  300. Unsaturated fatty acids intake and all-causes mortality: a 8.5-year follow-up of the Italian Longitudinal Study on Aging

    Article • Experimental Gerontology, April 2005, Elsevier

    Francesco Panza

  301. Polymorphisms in the Oxidized Low-Density Lipoprotein Receptor-1 Gene and Risk of Alzheimer's Disease

    Article • The Journals of Gerontology Series A, March 2005, Oxford University Press (OUP)

    Francesco Panza

  302. Italian Project on Epidemiology of Alzheimer’s disease (I.PR.E.A.): study design and methodology of cross-sectional survey

    Article • Aging Clinical and Experimental Research, February 2005, Springer Science + Business Media

    Francesco Panza

  303. Molecular Determinants of Human Longevity

    Article • January 2005, Elsevier

    Francesco Panza

  304. Vascular risk factors, incidence of MCI, and rates of progression to dementia

    Article • Neurology, November 2004, Wolters Kluwer Health

    Francesco Panza

  305. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe

    Article • Experimental Gerontology, October 2004, Elsevier

    Francesco Panza

  306. Mediterranean diet and cognitive decline

    Article • Public Health Nutrition, October 2004, Cambridge University Press

    Francesco Panza

  307. Interleukin 6 −174 G/C promoter gene polymorphism in centenarians: no evidence of association with human longevity or interaction with apolipoprotein E alleles

    Article • Experimental Gerontology, July 2004, Elsevier

    Francesco Panza

  308. Vascular genetic factors and human longevity

    Article • Mechanisms of Ageing and Development, March 2004, Elsevier

    Francesco Panza

  309. Regional European differences in allele and genotype frequencies of low density lipoprotein receptor-related protein 1 polymorphism in Alzheimer's disease

    Article • American Journal of Medical Genetics, January 2004, Wiley

    Francesco Panza

  310. Vascular risk and genetics of sporadic late-onset Alzheimer’s disease

    Article • Acta Neurovegetativa, December 2003, Springer Science + Business Media

    Francesco Panza

  311. Semantic Dementia: Neuropsychological and Behavioral Patterns in Relation to Hemispheric Asymmetries

    Article • American Journal of Geriatric Psychiatry, December 2003, Elsevier

    Francesco Panza

  312. Semantic Dementia

    Article • American Journal of Geriatric Psychiatry, November 2003, Elsevier

    Francesco Panza

  313. Angiotensin I converting enzyme (ACE) gene polymorphism in centenarians: Different allele frequencies between the North and South of Europe

    Article • Experimental Gerontology, September 2003, Elsevier

    Francesco Panza

  314. Shifts in angiotensin I converting enzyme insertion allele frequency across Europe: implications for Alzheimer's disease risk

    Article • Journal of Neurology Neurosurgery & Psychiatry, August 2003, BMJ

    Francesco Panza

  315. Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer’s disease patients and centenarians

    Article • Neuroreport, March 2003, Wolters Kluwer Health

    Francesco Panza

  316. Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease

    Article • Journal of Neurology Neurosurgery & Psychiatry, June 2002, BMJ

    Francesco Panza

  317. Selective Attention Skills in Differentiating between Alzheimer's Disease and Normal Aging

    Article • Journal of Geriatric Psychiatry and Neurology, June 2002, SAGE Publications

    Francesco Panza

  318. Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients ≥65 years of age (The Italian Longitudinal Study on Aging)

    Article • The American Journal of Cardiology, April 2002, Elsevier

    Francesco Panza

  319. Symbol Cancellation Test

    Article • January 2002, American Psychological Association (APA)

    Francesco Panza

  320. Apolipoprotein and antiotensin converting enzyme genes: regional differences and extreme longevity in Europe

    Article • Archives of Gerontology and Geriatrics, January 2002, Elsevier

    Francesco Panza

  321. F175S Change and a Novel Polymorphism in Presenilin-1 Gene in Late-Onset Familial Alzheimer’s Disease

    Article • European Neurology, January 2002, Karger Publishers

    Francesco Panza

  322. Lack of association between ace polymorphism and Alzheimer's disease in southern Italy

    Article • Archives of Gerontology and Geriatrics, January 2002, Elsevier

    Francesco Panza

  323. Lipoprotein(a) in the elderly: beyond atherosclerosis

    Article • Archives of Gerontology and Geriatrics, January 2002, Elsevier

    Francesco Panza

  324. Serum apoliprotein E levels in alzheimer's disease and extreme longevity

    Article • Archives of Gerontology and Geriatrics, January 2002, Elsevier

    Francesco Panza

  325. Analysis of individual items of mini-mental state examination in discrimination between normal and demented subjects

    Article • Archives of Gerontology and Geriatrics, January 2001, Elsevier

    Francesco Panza, Professor Michele Barone

  326. Impact of decreased frequency of apolipoprotein E ε4 allele on Alzheimer's disease in Southern Italy

    Article • Archives of Gerontology and Geriatrics, January 2001, Elsevier

    Francesco Panza

  327. Apolipoprotein E in Southern Italy: protective effect of ε2 allele in early- and late-onset sporadic Alzheimer's disease

    Article • Neuroscience Letters, October 2000, Elsevier

    Francesco Panza

  328. Lipoprotein(A) affects cognitive function in the elderly. The Italian longitudinal study on aging

    Article • Neurobiology of Aging, May 2000, Elsevier

    Francesco Panza

  329. Lipoprotein(A) is a risk factor for Alzheimer's disease independently of apolipoprotein E genotype

    Article • Neurobiology of Aging, May 2000, Elsevier

    Francesco Panza

  330. Decreased frequency of apolipoprotein E ε4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians

    Article • Neuroscience Letters, December 1999, Elsevier

    Francesco Panza

  331. High monounsaturated fatty acids intake protects against age-related cognitive decline

    Article • Neurology, May 1999, Wolters Kluwer Health

    Francesco Panza

  332. Efficacy of Cytidine Diphosphate Choline in Patients Affected by Chronic Cerebrovascular Disease

    Article • Clinical Drug Investigation, July 1996, Springer Science + Business Media

    Francesco Panza

  333. Analysis of some aspects of learning and memorization processes in an adult population

    Article • Archives of Gerontology and Geriatrics, January 1996, Elsevier

    Francesco Panza

  334. Correlation between neuropsychometric tests and semiquantitative evaluation of the regional cerebral blood flow (RCBF) in a group of outpatients affected by cognitive impairment

    Article • Archives of Gerontology and Geriatrics, January 1996, Elsevier

    Francesco Panza

  335. Impact of aging on the relationships between impairment of “Orientation” and “Recall” items of MMSE and mild to moderate mood disorders

    Article • Archives of Gerontology and Geriatrics, January 1996, Elsevier

    Francesco Panza

  336. Abstract

    Article • eLife

    Dr. Anwar Mahmoud Batieha, Dr Andre Luiz Sena Guimaraes, Francesco Panza, Professor Yousef Khader, Axel Carlsson